Ortiz and colleagues [2] sought to compare the efficacy of amiodarone vs procainamide in patients with hemodynamically stable, regular WCT. The exact diagnosis (eg, VT vs supraventricular tachycardia ...

King of Prussia, PA - The FDA has approved a novel formulation of amiodarone hydrochloride for intravenous (IV) use (Nexterone injection) that doesn't include polysorbate 80 or benzyl alcohol, ...

Amiodarone HCl 50mg/mL; soln for IV infusion after dilution; contains polysorbate 80. Amiodarone, a class III antiarrhythmic, possesses electrophysiologic characteristics of all four Vaughan Williams ...

Amiodarone is a class III antiarrhythmic drug, with some class IA properties. Amiodarone on rare occasions can induce torsades de pointes within the first 48 hours of intravenous administration, even ...

KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...

KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the supplemental new drug application for ...

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...

Recent-onset atrial fibrillation, defined as an onset within one week, is a major issue in clinical practice, and recent advances have shown that cardioversion to normal sinus rhythm provides better ...

(HealthDay)—In a report published online July 16 in the Journal of Clinical Pharmacy and Therapeutics, a case of survival after acute liver failure secondary to amiodarone administration is described.

KING OF PRUSSIA, Pa., Jan. 5 Prism Pharmaceuticalsannounced today that the U.S. Food & Drug Administration (FDA) has approvedthe new drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, ...